Drugs / FluMist® Quadrivalent
FluMist® Quadrivalent
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03898986 | Oct 2019 → Dec 2023 | influenza | Stanford University | Completed | No outcome recorded |
| Phase 1 | NCT03088904 | Oct 2014 → Dec 2018 | influenza | Stanford University | Completed | No outcome recorded |
| Phase 1 | NCT02950688 | ? → Dec 2020 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02474901 Comparator | Jul 2013 → Mar 2016 | HIV infectious disease | University of Colorado, Denver | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2023-10-24 | AstraZeneca | US Food and Drug Administration accepts for review AstraZeneca’s Supplemental Biologics License Application for self-administration of FluMist Quadrivalent astrazeneca.com ↗ |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FluMist Quadrivalent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03088904 ↗ |
| Known as | Live attenuated influenza vaccine (LAIV4) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03898986 ↗ |
| Known as | Quadrivalent Live Attenuated Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02474901 ↗ |
| Known as | Seasonal LAIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02950688 ↗ |
| Modality | Vaccine | “QLAIV is an intranasal vaccine” NCT02474901 ↗ |
| Route | Intranasal | “QLAIV is an intranasal vaccine” NCT02474901 ↗ |